News

all News



28 November 2016

Novimmune appoints Global Head of Project Management

Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs, announced today the appointment of Guillaume de Sampaïo as Global Head of Project Management and member of the company’s Senior Management Team.

Read more

19 September 2016

Novimmune broadens Senior Management Team

Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs, announced today two new appointments to its Senior Management Team, Chief Financial Officer (CFO) Sven Zimmermann, and Global Head of Quality Mylène Fleurant.

Read more

05 September 2016

Novimmune receives milestone payment from collaboration with Genentech

Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs, announced today that under its agreement with Genentech, a member of the Roche Group, a milestone triggering a payment has been achieved. Genentech dosed the first patient in a Phase I dose-escalation clinical trial in healthy volunteers and asthma patients with an investigational medicine to target inflammation associated with asthma. Financial terms have not been disclosed.

Read more